Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane

Journal of Molecular Medicine

Volumn 85, Issue 5, 2007, Pages 451-460

  Brand, Marcus ^a,b   Lamandé, Noël ^a   Larger, Etienne ^a   Corvol, Pierre ^a   Gasc, Jean Marie ^a  

^a INSERM   (France)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Angiotensinogen; Apoptosis; Cell transplantation; Chick chorioallantoic membrane; Endothelial cell proliferation; Endothelial growth factors

Indexed keywords

ANGIOTENSINOGEN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; RECOMBINANT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD VESSEL; CELL PROLIFERATION; CHICK; CHO CELL; CHORIOALLANTOIS; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; IN SITU HYBRIDIZATION; MESODERM; NICK END LABELING; NONHUMAN;

ANGIOGENESIS INHIBITORS; ANGIOTENSINOGEN; ANIMALS; APOPTOSIS; CAPILLARIES; CELL PROLIFERATION; CHICK EMBRYO; CHO CELLS; CHORIOALLANTOIC MEMBRANE; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; ENDOTHELIN-1; HUMANS; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; TIME FACTORS; TRANSFECTION;

EID: 34247881844     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0141-6     Document Type: Article

References (29)

1. Tewksbury DA (1990) Angiotensinogen: biochemistry and molecular biology. In: Laragh JH, Brenner BM (eds) Hypertension. Raven, New York, pp 1197-1216
2. Celerier J, Schmid G, Le Caer JP, Gimenez-Roqueplo AP, Bur D, Friedlein A, Langen H, Corvol P, Jeunemaitre X (2000) Characterization of a human angiotensinogen cleaved in its reactive center loop by a proteolytic activity from Chinese hamster ovary cells. J Biol Chem 275:10648-10654
3. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526-529
4. Zhang M, Volpert O, Shi YH, Bouck N (2000) Maspin is an angiogenesis inhibitor. Nat Med 6:196-199
5. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248
6. Miao RQ, Agata J, Chao L, Chao J (2002) Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood 100:3245-3252
7. Larsson H, Sjoblom T, Dixelius J, Ostman A, Ylinenjarvi K, Bjork I, Claesson-Welsh L (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells. Cancer Res 60:6723-6729
8. Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P (2002) Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension 39:224-228
9. Bouquet C, Lamandé N, Brand M, Gasc JM, Jullienne B, Faure G, Griscelli F, Opolon P, Connault E, Perricaudet M, Corvol P (2006) Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen. Mol Ther 14:175-182
10. Auerbach R, Kubai L, Knighton D, Folkman J (1974) A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 41:391-394
11. Wei L, Gaillard I, Corvol P, Clauser E (1988) Expression and characterization of recombinant human angiotensinogen in a heterologous eukaryotic cell line. Biochem Biophys Res Commun 156:1103-1110
12. Gimenez-Roqueplo AP, Leconte I, Cohen P, Simon D, Guyene TT, Celerier J, Pau B, Corvol P, Clauser E, Jeunemaitre X (1996) The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem 271:9838-9844
13. Parnot C, Le Moullec JM, Cousin MA, Guedin D, Corvol P, Pinet F (1997) A live-cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension 30:837-844
14. Genain C, Bouhnik J, Tewksbury D, Corvol P, Menard J (1984) Characterization of plasma and cerebrospinal fluid human angiotensinogen and des-angiotensin I-angiotensinogen by direct radioimmunoassay. J Clin Endocrinol Metab 59:478-484
15. Cruz A, Parnot C, Ribatti D, Corvol P, Gasc JM (2001) Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res 38:536-545
16. Larger E, Marre M, Corvol P, Gasc JM (2004) Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 53:752-761
17. Sibony M, Commo F, Callard P, Gasc JM (1995) Enhancement of mRNA in situ hybridization signal by microwave heating. Lab Invest 73:586-591
18. Favier J, Kempf H, Corvol P, Gasc JM (1999) Cloning and expression pattern of EPAS1 in the chicken embryo. Colocalization with tyrosine hydroxylase. FEBS Lett 462:19-24
19. Kempf H, Linares C, Corvol P, Gasc JM (1998) Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives. Development 125:4931-4941
20. Ribatti D, Nico B, Vacca A, Roncali L, Burri PH, Djonov V (2001) Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat Rec 264:317-324
21. Romanoff A (1960) The Avian Embryo. Structural and functional development. The Macmillan Company, New York
22. le Noble F, Fleury V, Pries A, Corvol P, Eichmann A, Reneman RS (2005) Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res 65:619-628
23. le Noble FA, Kessels-van Wylick LC, Hacking WJ, Slaaf DW, oude Egbrink MG, Struijker-Boudier HA (1996) The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network. J Vasc Res 33:480-488
24. Brand M, Lamandé N, Sigmund CD, Larger E, Corvol P, Gasc JM (2006) Angiotensinogen modulates renal vasculature growth. Hypertension 47:1067-1074
25. Machado RD, Santos RA, Andrade SP (2000) Opposing actions of angiotensins on angiogenesis. Life Sci 66:67-76
26. Cher ML, Biliran HR Jr, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S (2003) Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A 100:7847-7852
27. Biliran H Jr, Sheng S (2001) Pleiotropic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61:8676-8682
28. Blacque OE, Worrall DM (2002) Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277:10783-10788
29. Jiménez B, Volpert OV (2001) Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 78:663-672